메뉴 건너뛰기




Volumn 23, Issue 2-3, 2000, Pages 535-542

In-use testing of extemporaneously prepared suspensions of second generation non-nucleoside reversed transcriptase inhibitors in support of Phase I clinical studies

Author keywords

Dissolution; HPLC; NNRTI; Suspension

Indexed keywords

4 CYCLOPROPYLETHYNYL 5,6 DIFLUORO 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE; 6 CHLORO 4 CYCLOPROPYLETHYNYL 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ORA PLUS; ORA SWEET; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

EID: 0034663889     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(00)00337-X     Document Type: Article
Times cited : (4)

References (6)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.